WuXi Biologics (Cayman) Inc. WuXi Biologics (Cayman) Inc.

WuXi Biologics (Cayman) Inc.

2269

Rankning i aktier #985
Headquartered in Wuxi, China, and established in 2014, WuXi Biologics (Cayman)... Headquartered in Wuxi, China, and established in 2014, WuXi Biologics (Cayman) Inc. delivers a comprehensive, integrated suite of services spanning the entire biologics lifecycle, from initial discovery through development to large-scale manufacturing. The company's operations have a global footprint, serving clients across the People's Republic of China, North America, Europe, and other international regions. Its diversified offerings also include specialized consultation in biopharmaceutical technology, international sales contracting, the development and deployment of advanced testing methodologies, and robust marketing and sales support. Furthermore, WuXi Biologics is involved in providing dedicated biologics clinical and manufacturing services, the production and distribution of various medical products, contract development and manufacturing (CDMO) for vaccines and associated businesses, and acting as a supplier of key materials. The firm maintains strategic partnerships with notable entities such as ImmuneOncia Therapeutics, Legochem Biosciences Inc., Worg Pharma, OncoC4, and Exelixis Inc.
Aktiekurs
$5.77
Marknadsvärde
$23.74B
Förändring (1 dag)
-8.38%
Förändring (1 år)
25.13%
Land
CN
Handel WuXi Biologics (Cayman) Inc. (2269)

Kategori

Healthcare
Aktiekurshistorik för WuXi Biologics (Cayman) Inc. (2269)
Högsta slutkurs: $6.65 den 2026-10-01

Lägsta slutkurs: $1.19 den 2017-06-01
Aktiekurshistorik för WuXi Biologics (Cayman) Inc. från 2017 till 2026
Årlig aktiekursutveckling
År Prestanda
2026 (TTM) 17.26%
2025 87.45%
2024 -41.69%
2023 -43.71%
2022 -43.37%
2021 8.58%
2020 173.84%
2019 69.74%
2018 28.79%
2017 0.00%
Aktiekurs för liknande företag eller konkurrenter
Företag Aktiekurs Förändring 1år% Land
$536.87 25.89%
US
$191.60 613.60%
US
$137.83 -3.78%
AU
$291.76 2.51%
BE
$884.30 8.61%
NL